| Lesion Preparation in Femoropopliteal Artery Occlusion Disease (NCT05473884) | Shanghai Pudong Hospital | 2022-06-01 |
| To Study and Explore the Predictive Effect of Insulin Resistance-related Indicators on In-stent Restenosis After Coronary Stent Implantation (NCT07614763) | Qilu Hospital of Shandong University | 2022-01-01 |
| A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (NCT04985773) | Infraredx | 2021-12-17 |
| CVT-ISR First in Human Trial for Coronary In-Stent Restenosis (NCT05731700) | Abbott Medical Devices | 2021-10-20 |
| A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (NCT04647253) | Boston Scientific Corporation | 2021-05-11 |
| Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis (NCT04240444) | B. Braun Medical International Trading Company Ltd. | 2020-10-10 |
| A Comparison Between FFR Guided and CAG Guided Treatment Using DEB in ISR of DES (NCT04518826) | Shanghai Zhongshan Hospital | 2020-10-01 |
| Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study (NCT04079192) | Biosensors Europe SA | 2020-08-07 |
| Coronary Laser in Undilatable or Uncrossable Lesions (NCT07206082) | Hospital Universitario La Paz | 2020-06-05 |
| In-stent Restenosis and Pericoronary Fat Attenuation Index (NCT05512832) | RenJi Hospital | 2020-01-01 |
| Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT (NCT04268875) | University Hospital, Clermont-Ferrand | 2019-12-11 |
| IVL for Stent Underexpantsion (NCT05112250) | Medical University of Silesia | 2019-11-01 |
| DEB vs Thin-DES in DES-ISR: Long Term Outcomes (DEB Dragon Registry) (NCT04415216) | Medical University of Silesia | 2019-10-10 |
| Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis (NCT03809754) | Chinese PLA General Hospital | 2019-03-01 |
| The Effect of Sleep Quality on Coronary Artery Disease and In Stent Restenosis (NCT03874481) | China National Center for Cardiovascular Diseases | 2018-11-01 |
| Metal Allergy In-Stent Restenosis Study (NCT03588962) | Silesian Centre for Heart Diseases | 2018-10-01 |
| LDD in Treatment of Femoropopliteal ISR (NCT03521843) | RenJi Hospital | 2018-01-01 |
| The PREVAIL Study (NCT03260517) | Medtronic Vascular | 2017-10-02 |
| Comparing the Safety and Efficacy of Paclitaxel Controlled Release Balloon Catheter in the Treatment of In-stent Restenosis of Coronary Artery Lesion With Paclitaxel Release Coronary Balloon Catheter (NCT02891018) | Shandong Branden Med.Device Co.,Ltd | 2015-12-01 |
| Absorb Bioresorbable Scaffold vs. Drug Coated Balloon for Treatment Of In-Stent-Restenosis (NCT03529006) | Luzerner Kantonsspital | 2015-03-01 |
| Identification of Neoatherosclerosis in ISR Patients Based on Artifical Intelligence (NCT04220437) | Chinese PLA General Hospital | 2015-02-01 |
| Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (NCT01255956) | Medical University of Warsaw | 2010-12-01 |
| DARE-trial: A Trial Studying the Effect of the SeQuent Please Drug-eluting Balloon Compared to the Xience Prime Drug-eluting Stent for the Treatment of Stenosis of an Earlier Implanted Stent. (NCT01127958) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-05-01 |
| RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (NCT01239940) | Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular | 2010-01-01 |
| RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (NCT01239953) | Fundación Médica para la Investigación y Desarrollo en el Area Cardiovascular | 2010-01-01 |
| Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter (NCT00998439) | Klinikum Coburg | 2009-10-01 |
| PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis (NCT00916279) | C. R. Bard | 2009-06-01 |
| Focal In-stent Restenosis After Drug-Eluting Stent (NCT00485004) | Seung-Jung Park | 2007-03-01 |
| Diffuse Type In-Stent Restenosis After Drug-Eluting Stent (NCT00485030) | Seung-Jung Park | 2007-03-01 |
| P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses (NCT00393315) | University Hospital, Saarland | 2005-11-01 |
| Genomics of In-Stent Restenosis (NCT00341562) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-09-01 |
| Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR) (NCT00231257) | Cordis US Corp. | 2003-02-01 |